Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease.
Fang J, Zhang P, Wang Q, Chiang CW, Zhou Y, Hou Y, Xu J, Chen R, Zhang B, Lewis SJ, Leverenz JB, Pieper AA, Li B, Li L, Cummings J, Cheng F.
Fang J, et al. Among authors: xu j.
Alzheimers Res Ther. 2022 Jan 10;14(1):7. doi: 10.1186/s13195-021-00951-z.
Alzheimers Res Ther. 2022.
PMID: 35012639
Free PMC article.